glp 1 for premenopausal woman Microdosing GLP-1 Perimenopause: Why Lower Doses Might Be Better Weight Gain During Menopause: Solutions

GLP-1 medications like semaglutide are available on the NHS only through specialist weight management services if you meet strict criteria: typically BMI 35 kg/m with at least one weight-related comorbidity such as type 2 diabetes or hypertension

We actually have clinical data on this

This content is not a substitute for professional medical advice, diagnosis, or treatment

The clinical value of GLP-1 therapy depends on the patient, the indication, the dose, the response, the side effects, the nutrition plan, the muscle-preservation strategy, and the larger medical context

[1] For Hashimoto's patients specifically, there are additional concerns

See all FAQs Important safety information and common side effects Do not use with other GLP-1 receptor agonist medications, or any other products containing GLP-1s